Conventional patterns of human intestinal proliferation in a severe-combined immunodeficient xenograft model.
The present work describes the pattern of human intestinal proliferation in an immunodeficient murine xenograft model, which we have shown to closely mimic cell division in normal paediatric gut. Cellular proliferation was measured using a double-label technique combining MIB-1 immunohistochemistry and [3H]thymidine autoradiography, to critically compare values for the tissue growth fraction (G1, G2, S- and M-phase cells) and DNA synthesizing (S-phase) cells in xenograft epithelium, lamina propria, muscularis externa and intraepithelial lymphocytes. The MIB-1 monoclonal antibody (which recognises the cell-cycle dependent nuclear antigen Ki-67) specifically labelled proliferating human cells within the xenografts and did not cross-react with dividing murine cells. This was confirmed using ultrastructural in situ hybridisation with human- and mouse-specific DNA probes to identify the genetic origin of proliferating cells. In general, we found a good tissue correlation between MIB-1 and [3H]thymidine labelling, the only exception being an apparent dysregulation of Ki-67 antigen expression in regenerating xenograft epithelium. In developed xenograft intestine, the highest levels of proliferation were consistently recorded within the crypt epithelium, where 15.7%-26.7% of cells were actively cycling and S-phase occupied approximately half of the cell cycle. The frequency distribution of proliferating epithelial cells within small and large intestinal xenograft crypts was clearly tissue-specific, showing typical patterns of cell division. Therefore, the presence of functional pluripotent epithelial stem cells and conventional spatio-temporal patterns in cellular proliferation, migration, de-cycling, lineage commitment and cytodifferentiation now makes this an attractive experimental model with which to study human intestinal crypt responses to various types of tissue manipulation, e.g. cytotoxic, radiotherapeutic, dietary, endocrine and gene-targeting therapy.
Shmakov
A N
AN
Department of Cellular Physiology, Babraham Institute, Cambridge, UK.
Morey
A L
AL
Ferguson
D J
DJ
Fleming
K A
KA
O'Brien
J A
JA
Savidge
T C
TC
D000818:Animals; D000911:Antibodies, Monoclonal; D002455:Cell Division / Q000502:physiology; D004247:DNA / Q000378:metabolism; D004847:Epithelial Cells; D016332:Fetal Tissue Transplantation; D006801:Humans; D007150:Immunohistochemistry; D017403:In Situ Hybridization; D007223:Infant; D007420:Intestine, Large / Q000166:cytology* / Q000196:embryology / Q000637:transplantation*; D007421:Intestine, Small / Q000166:cytology* / Q000196:embryology / Q000637:transplantation*; D019394:Ki-67 Antigen / Q000032:analysis; D051379:Mice; D016513:Mice, SCID; D013936:Thymidine / Q000378:metabolism; D014183:Transplantation, Heterologous; D014316:Tritium
D000911:Antibodies, Monoclonal; D019394:Ki-67 Antigen; D014316:Tritium; D004247:DNA; D013936:Thymidine